EFS

Donors

Matching at HLA-A,-B,-C,-DRB1:

Matching at HLA-DQB1:

Matching at HLA-DPB1:

Donor CMV serostatus, pre-HCT:

Donor type:

Donor age:

Donor race:

Donor sex:

Donor ABO type:

Donor parity:

Graft source:

DPB1 permissive:

Matching at HLA-DQA1,-DPA1,-DRBX:

Patient

Recipient sex:

Disease / indication for transplant:

Refined disease risk index:

Recipient CMV serostatus, pre-HCT:

History of mechanical ventilation:

History of proven invasive fungal infection:

Reported planned conditioning intensity:

Recipient age:

Interval from diagnosis to transplant, months:

Recipient race:

HCT-CI score:

GVHD prophylaxis (major):

ATG/Campath use:

History of malignancy:

Recipient ABO type:

Karnofsky/Lansky performance score:

TBI dose groups:

Median household income ($) based on zipcode:

AML

MDS transformed to AML:

Therapy related AML:

Number of induction cycles to
achieve CR1 (AML):

Cytogenetic ELN risk group for AML:

ALL

Cytogenetic score (ALL):

Ph+ (ALL):

ALL immunophenotype:

BCR/ABL molecular marker at last
evaluation (ALL only):

MDS

Therapy related (MDS/MPN):

IPSS-R at diagnosis (MDS):

Disease risk prior to HCT (MDS):

Predisposing condition (MDS/MPN):

IPSS-R at transplant (MDS):